These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200 [TBL] [Abstract][Full Text] [Related]
7. Patterns of failure after radical prostatectomy in prostate cancer - implications for radiation therapy planning after Schiller K; Sauter K; Dewes S; Eiber M; Maurer T; Gschwend J; Combs SE; Habl G Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1656-1662. PubMed ID: 28646463 [TBL] [Abstract][Full Text] [Related]
8. Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy. Schmidt-Hegemann NS; Fendler WP; Ilhan H; Herlemann A; Buchner A; Stief C; Eze C; Rogowski P; Li M; Bartenstein P; Ganswindt U; Belka C Radiat Oncol; 2018 Mar; 13(1):37. PubMed ID: 29499730 [TBL] [Abstract][Full Text] [Related]
9. (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. van Leeuwen PJ; Stricker P; Hruby G; Kneebone A; Ting F; Thompson B; Nguyen Q; Ho B; Emmett L BJU Int; 2016 May; 117(5):732-9. PubMed ID: 26683282 [TBL] [Abstract][Full Text] [Related]
10. Interobserver variability, detection rate, and lesion patterns of Miksch J; Bottke D; Krohn T; Thamm R; Bartkowiak D; Solbach C; Bolenz C; Beer M; Wiegel T; Beer AJ; Prasad V Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2339-2347. PubMed ID: 32157427 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Prospective, Multisite, International Comparison of Emmett L; Metser U; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Punwani S; Pond G; Chua S; Ho B; Johnston E; Pouliot F; Scott AM J Nucl Med; 2019 Jun; 60(6):794-800. PubMed ID: 30442757 [TBL] [Abstract][Full Text] [Related]
13. Detection Rate and Localization of Prostate Cancer Recurrence Using Kranzbühler B; Müller J; Becker AS; Garcia Schüler HI; Muehlematter U; Fankhauser CD; Kedzia S; Guckenberger M; Kaufmann PA; Eberli D; Burger IA J Nucl Med; 2020 Feb; 61(2):194-201. PubMed ID: 31375566 [TBL] [Abstract][Full Text] [Related]
14. Vesico-urethral anastomosis sampling: a forgotten tool for guiding salvage radiation after radical prostatectomy. Timm B; Farag M; Liodakis P; Angus D; Lim Joon D; Bolton D BJU Int; 2021 May; 127 Suppl 1():23-29. PubMed ID: 33973332 [TBL] [Abstract][Full Text] [Related]
15. Patterns of relapse as determined by Henkenberens C; Derlin T; Bengel FM; Ross TL; Wester HJ; Hueper K; Kuczyk MA; Christiansen H; von Klot CA Strahlenther Onkol; 2018 Apr; 194(4):303-310. PubMed ID: 29134231 [TBL] [Abstract][Full Text] [Related]
16. Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy. Schmidt-Hegemann NS; Fendler WP; Buchner A; Stief C; Rogowski P; Niyazi M; Eze C; Li M; Bartenstein P; Belka C; Ganswindt U Radiat Oncol; 2017 Nov; 12(1):176. PubMed ID: 29126446 [TBL] [Abstract][Full Text] [Related]
17. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological predictors of positive Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860 [TBL] [Abstract][Full Text] [Related]